UnitedHealth Group Incorporated (UNH)
Latest news, insights and market data
Market Data
AI Insights
UnitedHealth is reshaping its approach to care delivery by tightening medical cost trends and eliminating prior authorization for various services, which could enhance patient access and experiences. However, investors should remain cautious about whether these changes might compromise cost discipline. This shift reflects a strategic pivot that could impact the company's operational efficiency going forward.
Latest News
| Title | Published |
|---|---|
Dividend Champion, Contender, And Challenger Highlights: Week September 6 Explore this weekâs dividend updates for Dividend Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend and pay dates. | about 8 hours ago |
2 Reasons to Like UNH and 1 to Stay Skeptical 2 Reasons to Like UNH and 1 to Stay Skeptical | about 12 hours ago |
2 Reasons to Like UNH and 1 to Stay Skeptical UnitedHealth’s 37.1% return over the past six months has outpaced the S&P 500 by 25.4%, and its stock price has climbed to $400.22 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation. | about 12 hours ago |
Which dow jones stocks are moving on Friday? Let's have a look at the top dow jones gainers and losers one hour before the close of the markets of today's session. | about 12 hours ago |
UnitedHealth Falls as 30% of Approval Barriers Vanish UnitedHealth Falls as 30% of Approval Barriers Vanish | about 14 hours ago |
UnitedHealth Falls as 30% of Approval Barriers Vanish Less paperwork may improve access, but investors must watch whether faster approvals weaken medical-cost discipline. | about 14 hours ago |
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy? UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy? | about 15 hours ago |
Dividend Champion, Contender, And Challenger Highlights: Week September 6
Explore this weekâs dividend updates for Dividend Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend and pay dates.
2 Reasons to Like UNH and 1 to Stay Skeptical
2 Reasons to Like UNH and 1 to Stay Skeptical
2 Reasons to Like UNH and 1 to Stay Skeptical
UnitedHealth’s 37.1% return over the past six months has outpaced the S&P 500 by 25.4%, and its stock price has climbed to $400.22 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Which dow jones stocks are moving on Friday?
Let's have a look at the top dow jones gainers and losers one hour before the close of the markets of today's session.
UnitedHealth Falls as 30% of Approval Barriers Vanish
UnitedHealth Falls as 30% of Approval Barriers Vanish
UnitedHealth Falls as 30% of Approval Barriers Vanish
Less paperwork may improve access, but investors must watch whether faster approvals weaken medical-cost discipline.
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?